(Q79434775)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17170722%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

In vivo apoptosis of CD8(+) lymphocytes in acute myeloid leukemia patients: involvement of soluble HLA-I and Fas ligand (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17170722%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

main subject

acute myeloid leukemia

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17170722%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Alessandro Poggi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17170722%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Contini P

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17170722%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Pierri I

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17170722%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Albarello A

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17170722%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

14 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17170722%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17170722%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17170722%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17170722%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

253-260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17170722%20AND%20SRC:MED&resulttype=core&format=json

Soluble HLA class I molecules: biological significance and clinical implications

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Structure of the human class I histocompatibility antigen, HLA-A2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Soluble HL-A7 Antigen: Localization in the β-Lipoprotein Fraction of Human Serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Anti HL-A2 Inhibitor in Normal Human Serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Report of the second international soluble HLA (sHLA) workshop. Phoenix, Arizona, October 2, 1993.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Serum HLA class I antigens: markers and modulators of an immune response?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Biochemical and immunological evaluation of donor-specific soluble HLA in the circulation of liver transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Quantification of serum-soluble HLA class I antigens in patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Clinical significance of soluble form of HLA class I molecule in Japanese patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Increased Soluble Serum HLA Class I Antigens in Patients with Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Allorecognition of purified major histocompatibility complex glycoproteins by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Interaction of papain-digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Natural killer clones recognize specific soluble HLA class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Transendothelial migration leads to protection from starvation-induced apoptosis in CD34+CD14+ circulating precursors: evidence for PECAM-1 involvement through Akt/PKB activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

BCL-2 family: regulators of cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

The CD95 type I/type II model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Death receptor-induced cell killing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Organ graft tolerance: the liver effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Secretion of sHLA-G molecules in malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Reversal of drug-resistance by cyclosporin-A in a patient with acute myelocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021

Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404494

7 January 2021